Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Sex differences in early ventricular fibrillation among patients with fulminant myocarditis in a nationwide registry.

Created on 22 Sep 2026

Authors

Keishi Moriwaki, Koshiro Kanaoka, Kenji Onoue, Yoshihiko Saito, Kaoru Dohi

Published in

Heart (British Cardiac Society). Sep 21, 2026. Epub Sep 21, 2026.

Abstract

Fulminant myocarditis is a rare but life-threatening condition frequently complicated by malignant ventricular arrhythmias. Data on sex differences in early ventricular fibrillation (VF) in fulminant presentation are limited.
We conducted a retrospective nationwide multicentre cohort study using the Japanese Registry of Fulminant Myocarditis between 2012 and 2017. Fulminant presentation was defined as prodromal symptoms within 4 weeks and the need for catecholamines and/or mechanical circulatory support within 14 days of admission. The primary endpoint was VF within 30 days after admission. We estimated the 30-day cumulative incidence of VF and used Fine-Gray competing-risk regression (death as the competing event) to evaluate the association with sex.
Among 696 patients (40% female), VF within 30 days occurred in 120 (17%). Female patients had a higher 30-day incidence of VF than male patients (22% vs 14%; p=0.006). In multivariable complete-case analysis adjusting for age, left ventricular ejection fraction on admission, estimated glomerular filtration rate and peak creatine kinase, female sex was associated with 30-day VF (subdistribution HR, 1.58; 95% CI 1.09 to WHAT IS ALREADY KNOWN ON THIS TOPIC2.28; p=0.016). Ninety-day all-cause mortality was 36% in female patients and 34% in male patients (p=0.732).
In a nationwide registry of fulminant myocarditis, female sex was associated with a higher risk of early VF, whereas there was no clear evidence of a sex difference in 90-day all-cause mortality. Incorporating sex into early risk assessment may help tailor acute monitoring and management strategies in this high-risk condition.

PMID:
42767834
Bibliographic data and abstract were imported from PubMed on 22 Sep 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 21
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement